 |
 |
 |
For Market’s Latest Update Join Us on Telegram
 |
Objective of the Issue
The objects of the present issue of Equity Shares are:
- Capital expenditure towards purchase of new equipment/machineries, etc.
- Capital expenditure towards upgradation of existing manufacturing facility.
- Repayment/prepayment of certain borrowings availed by our Company.
- Funding working capital requirements.
- General Corporate Purpose.
IPO Details, Price, Market Lot
| Accretion Pharmaceuticals IPO Details | |
| IPO Open Date | 14 May 2025 |
| IPO Close Date | 16 May 2025 |
| IPO Issue Size | 29,46,000 shares (Aggregating up to ₹29.75 Cr) |
| Fresh Issue | 29,46,000 shares (Aggregating up to ₹29.75 Cr) |
| Offer for Sale | NIL |
| Retail Portion | Not less than 35.00% of the offer |
| NII Portion | Not less than 15.00% of the offer |
| QIB Portion | Not more than 50.00% of the offer |
| Listing At | NSE SME |
| Accretion Pharmaceuticals IPO Price | |
| Face Value | ₹10 per share |
| IPO Price Band | ₹96 to ₹101 per share |
| IPO Issue Type | Book Built Issue |
| Accretion Pharmaceuticals IPO Time Table (Tentative) | |
| IPO Open Date | 14 May 2025 |
| IPO Close Date | 16 May 2025 |
| Basis of Allotment Date | 19 May 2025 |
| Initiation of Refunds | 20 May 2025 |
| Credit of Share to Demat Account | 20 May 2025 |
| IPO Listing Date | 21 May 2025 |
| Company Promotor & Promotor’s Holding | |
| Mr. Mayur Popatlal Sojitra, Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel and Mr. Hardik Mukundbhai Prajapati are the promoter’s of company. | |
| Pre Issue Promotor Holding | 100.00% |
| Post Issue Promotor Holding | 73.48% |
| Company’s Contact & Address | |
| Accretion Pharmaceuticals Limited 29 Xcelon Ind Park 1, B/h, Intas Pharmaceuticals, Vasna Chacharvad, Ahmedabad, Sanand, Gujarat, India, 382213 Phone: +91-97148 82929 Email: compliance@accretionpharma.com Website: https://accretionpharma.com/ |
|
| Accretion Pharmaceuticals IPO Registrar, Lead Manager, Prospectus | |
| IPO Prospectus | |
| IPO Registrar | |
| Kfin Technologies Limited | |
| IPO Lead Manager | |
| Jawa Capital Services Private Limited | |
Accretion Pharmaceuticals SME IPO Lot Size
| Number of Shares Per Lot = 1,200 shares | |||
| Application | Lot(s) | Shares | Amount |
| Retail (Minimum) | 1 | 1,200 | ₹1,21,200 |
| Retail (Maximum) | 1 | 1,200 | ₹1,21,200 |
| HNI (Minimum) | 2 | 2,400 | ₹2,42,400 |
| Number of Shares Per Lot = 1,200 shares | |||
| Application | Lot(s) | Shares | Amount |
| Retail (Min) | 1 | 1,200 | ₹1,21,200 |
| Retail (Max) | 1 | 1,200 | ₹1,21,200 |
| HNI (Mini) | 2 | 2,400 | ₹2,42,400 |
Financial Report
| Period Ended | Assets (₹ in Lakh) |
Revenue (₹ in Lakh) |
P A T (₹ in Lakh) |
Net Worth (₹ in Lakh) |
Borrowings (₹ in Lakh) |
| 31 December 2024 | 3,998.83 | 3,574.93 | 523.55 | 1,358.31 | 1378.98 |
| 31 March 2024 | 2,704.61 | 3,393.86 | 387.53 | 534.76 | 1348.22 |
| 31 March 2023 | 2,057.97 | 2,953.15 | 10.39 | 384.27 | 846.58 |
| 31 March 2022 | 1,774.12 | 2,258.42 | 7.90 | 307.64 | 760.95 |
| Period Ended | 31 Dec. 2024 | 31 March 2024 | 31 March 2023 | 31 March 2022 |
| Assets | 3,998.83 | 2,704.61 | 2,057.97 | 1,774.12 |
| Revenue | 3,574.93 | 3,393.86 | 2,953.15 | 2,258.42 |
| P A T | 523.55 | 387.53 | 10.39 | 7.90 |
| Net Worth | 1,358.31 | 534.76 | 384.27 | 307.64 |
| Borrowings | 1378.98 | 1348.22 | 846.58 | 760.95 |
| Amount in ₹ Lakh | ||||